Esophageal carcinoma: Towards targeted therapies-Reference-Cited by-同舟云学术

Esophageal carcinoma: Towards targeted therapies

Published:2019-12-17 Issue:2 Volume:43 Page:195-209
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Fatehi Hassanabad Ali,Chehade Rania,Breadner Daniel,Raphael Jacques

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13402-019-00488-2.pdf

Reference93 articles.

1. J. Lagergren, E. Smyth, D. Cunningham, P. Lagergren, Oesophageal cancer. Lancet 390, 2383–2396 (2017)

2. Cancer Genome Atlas Research Network; Analysis Working Group: Asan University; BC Cancer Agency; Brigham and Women’s Hospital; Broad Institute; Brown University; Case Western Reserve University; Dana-Farber Cancer Institute; Duke University; Greater Poland Cancer Centre; Harvard Medical School; Institute for Systems Biology; KU Leuven; Mayo Clinic; Memorial Sloan Kettering Cancer Center; National Cancer Institute; Nationwide Children’s Hospital; Stanford University; University of Alabama; University of Michigan; University of North Carolina; University of Pittsburgh; University of Rochester; University of Southern California; University of Texas MD Anderson Cancer Center; University of Washington; Van Andel Research Institute; Vanderbilt University; Washington University; Genome Sequencing Center: Broad Institute; Washington University in St. Louis; Genome Characterization Centers: BC Cancer Agency; Broad Institute; Harvard Medical School; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; University of North Carolina; University of Southern California Epigenome Center; University of Texas MD Anderson Cancer Center; Van Andel Research Institute; Genome Data Analysis Centers: Broad Institute; Brown University:; Harvard Medical School; Institute for Systems Biology; Memorial Sloan Kettering Cancer Center; University of California Santa Cruz; University of Texas MD Anderson Cancer Center; Biospecimen Core Resource: International Genomics Consortium; Research Institute at Nationwide Children’s Hospital; Tissue Source Sites: Analytic Biologic Services; Asan Medical Center; Asterand Bioscience; Barretos Cancer Hospital; BioreclamationIVT; Botkin Municipal Clinic; Chonnam National University Medical School; Christiana Care Health System; Cureline; Duke University; Emory University; Erasmus University; Indiana University School of Medicine; Institute of Oncology of Moldova; International Genomics Consortium; Invidumed; Israelitisches Krankenhaus Hamburg; Keimyung University School of Medicine; Memorial Sloan Kettering Cancer Center; National Cancer Center Goyang; Ontario Tumour Bank; Peter MacCallum Cancer Centre; Pusan National University Medical School; Ribeirão Preto Medical School; St. Joseph’s Hospital &Medical Center; St. Petersburg Academic University; Tayside Tissue Bank; University of Dundee; University of Kansas Medical Center; University of Michigan; University of North Carolina at Chapel Hill; University of Pittsburgh School of Medicine; University of Texas MD Anderson Cancer Center; Disease Working Group: Duke University; Memorial Sloan Kettering Cancer Center; National Cancer Institute; University of Texas MD Anderson Cancer Center; Yonsei University College of Medicine; Data Coordination Center: CSRA Inc.; Project Team: National Institutes of Health, Integrated genomic characterization of oesophageal carcinoma. Nature 541, 169–175 (2017)

3. Y.B. Gao, Z.L. Chen, J.G. Li, X.D. Hu, X.J. Shi, Z.M. Sun, F. Zhang, Z.R. Zhao, Z.T. Li, Z.Y. Liu, Y.D. Zhao, J. Sun, C.C. Zhou, R. Yao, S.Y. Wang, P. Wang, N. Sun, B.H. Zhang, J.S. Dong, Y. Yu, M. Luo, X.L. Feng, S.S. Shi, F. Zhou, F.W. Tan, B. Qiu, N. Li, K. Shao, L.J. Zhang, Q. Xue, S.G. Gao, J. He, Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 46, 1097–1102 (2014)

4. D.C. Lin, J.J. Hao, Y. Nagata, L. Xu, L. Shang, X. Meng, Y. Sato, Y. Okuno, A.M. Varela, L.W. Ding, M. Garg, L.Z. Liu, H. Yang, D. Yin, Z.Z. Shi, Y.Y. Jiang, W.Y. Gu, T. Gong, Y. Zhang, X. Xu, O. Kalid, S. Shacham, S. Ogawa, M.R. Wang, H.P. Koeffler, Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet 46, 467–473 (2014)

5. C.C. Abnet, M. Arnold, W.Q. Wei, Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154, 360–373 (2018)

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circ_FNDC3B Promotes Cell Proliferation and Metastasis in Esophageal Squamous Cell Carcinoma via Regulating MAPK1 by Binding to miR-136-5p;Biochemical Genetics;2024-01-16

2. IDO1 facilitates esophageal carcinoma progression by driving the direct binding of NF-κB and CXCL10;Cell Death Discovery;2023-10-31

3. Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review;Current Oncology;2023-10-30

4. RGS16 regulates Hippo-YAP activity to promote esophageal cancer cell proliferation and migration;Biochemical and Biophysical Research Communications;2023-10

5. Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma;Cancer Science;2023-09-19